Relevance of urocortins to cardiovascular disease

Area of Science:

• Cardiovascular Science
• Endocrinology
• Molecular Medicine

Background:

• Acquired cardiovascular diseases (CVDs) are a leading cause of global mortality, often diagnosed late, limiting treatment efficacy.
• Existing therapies for CVDs are available, but understanding disease pathogenesis is crucial for improved diagnosis and therapeutic strategies.
• Urocortins, peptides within the corticotrophin-releasing factor family, have demonstrated both potentially beneficial and detrimental effects on the cardiovascular system.

Purpose of the Study:

• To review current literature on the role of urocortins in cardiovascular disease.
• To explore the potential of urocortins in diagnosis and treatment of cardiovascular conditions.
• To highlight emerging evidence favoring the beneficial effects of urocortins in cardiovascular health.

Main Methods:

• Literature review of pre-clinical and human association studies on urocortins and cardiovascular disease.
• Analysis of published data investigating the mechanisms of urocortins' effects on cardiac and vascular cells.
• Synthesis of evidence regarding urocortins' potential to inhibit reactive oxygen species and vascular cell apoptosis.

Main Results:

• Urocortins exhibit potential beneficial effects on the cardiovascular system.
• Evidence suggests urocortins can inhibit reactive oxygen species production.
• Urocortins have been shown to reduce vascular cell apoptosis, suggesting a role in disease antagonism.

Conclusions:

• Urocortins show promise as a potential therapeutic target for cardiovascular diseases.
• Further research into urocortins' mechanisms could lead to improved diagnostic and therapeutic strategies for CVDs.
• The beneficial effects of urocortins in mitigating cardiovascular disease progression warrant continued investigation.